← Leaderboards
Louise Catherine Ivers
Brigham And Women'S Hospital
$9,002,450
Attributed
$40,288,128
Total exposure
10
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.4M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$39,788,128 · 9
CDC$500,000 · 1
By mechanism
U19$30,500,379 · 7
R01$9,120,397 · 2
K23$667,352 · 1
Top collaborators
- Darrell P Chandler31 shared
- Aedin C Culhane31 shared
- Molly Forrest Franke31 shared
- Jerome Timothy Galea31 shared
- Anne Goldfeld31 shared
- Ann Chesney Miller31 shared
- Nira Pollock31 shared
- Eric Joseph Rubin31 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Arthur O Tzianabos$3,638,400
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationDiagnosisDiagnosticCostChildBaseDiagnostic TestsMycobacterium TuberculosisDrug ResistanceProgramsHaitiDrug Resistance In TuberculosisInfectionAdultPharmaceutical PreparationsFundingResourcesEvaluationCohortSiteMutationResistancePeruDesign
Grant awards (51)
Assessing measures to eliminate transmission of cholera in Haiti$1,072,308
R01 · FY2022 · AI
Assessing measures to eliminate transmission of cholera in Haiti$1,072,308
R01 · FY2020 · AI
Assessing measures to eliminate transmission of cholera in Haiti$1,072,308
R01 · FY2019 · AI
Sequencing Core$2,595,356
U19 · FY2018 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$1,274,314
U19 · FY2018 · AI
Discovery and validation of drug resistance mutations$938,261
U19 · FY2018 · AI
Assessing measures to eliminate transmission of cholera in Haiti$918,190
R01 · FY2018 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$888,730
U19 · FY2018 · AI
Administrative Core$412,046
U19 · FY2018 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$403,448
U19 · FY2018 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,182,203
U19 · FY2017 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$1,095,803
U19 · FY2017 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$913,253
U19 · FY2017 · AI
Discovery and validation of drug resistance mutations$734,112
U19 · FY2017 · AI
Administrative Core$616,131
U19 · FY2017 · AI
Sequencing Core$408,777
U19 · FY2017 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,528,705
U19 · FY2016 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$992,134
U19 · FY2016 · AI
Discovery and validation of drug resistance mutations$750,894
U19 · FY2016 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$715,308
U19 · FY2016 · AI
Immune Responses to Vibrio cholerae infection and vaccination in Haiti$700,752
R01 · FY2016 · AI
Sequencing Core$421,675
U19 · FY2016 · AI
Administrative Core$410,524
U19 · FY2016 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$82,633
U19 · FY2016 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,500,809
U19 · FY2015 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$932,090
U19 · FY2015 · AI
Discovery and validation of drug resistance mutations$774,241
U19 · FY2015 · AI
Immune Responses to Vibrio cholerae infection and vaccination in Haiti$698,624
R01 · FY2015 · AI
Sequencing Core$660,525
U19 · FY2015 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$500,331
U19 · FY2015 · AI
Administrative Core$311,434
U19 · FY2015 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,916,905
U19 · FY2014 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$900,727
U19 · FY2014 · AI
Immune Responses to Vibrio cholerae infection and vaccination in Haiti$899,151
R01 · FY2014 · AI
Sequencing Core$822,385
U19 · FY2014 · AI
Discovery and validation of drug resistance mutations$554,926
U19 · FY2014 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$536,059
U19 · FY2014 · AI
Administrative Core$225,640
U19 · FY2014 · AI
Immune Responses to Vibrio cholerae infection and vaccination in Haiti$670,764
R01 · FY2013 · AI
GH10-1003: BUILDING CAP. TO PROVIDE CERVICAL CANCER SCR. AND TREATMENT IN HAITI,$500,000
U19 · FY2013 · GH · contact PI
Tailored nutrition and food security interventions in comprehensive HIV care$72,426
R01 · FY2013 · HD · contact PI
Immune Responses to Vibrio cholerae infection and vaccination in Haiti$773,078
R01 · FY2012 · AI
Tailored nutrition and food security interventions in comprehensive HIV care$284,873
R01 · FY2012 · HD · contact PI
Tailored nutrition and food security interventions in comprehensive HIV care$283,277
R01 · FY2011 · HD · contact PI
Tailored nutrition and food security interventions in comprehensive HIV care$301,506
R01 · FY2010 · HD · contact PI
Tailored nutrition and food security interventions in comprehensive HIV care$300,832
R01 · FY2009 · HD · contact PI
Identifying HIV and related stigma in rural Haiti$133,520
K23 · FY2009 · AI · contact PI
Identifying HIV and related stigma in rural Haiti$133,520
K23 · FY2008 · AI · contact PI
Identifying HIV and related stigma in rural Haiti$133,520
K23 · FY2007 · AI · contact PI
Identifying HIV and related stigma in rural Haiti$133,520
K23 · FY2006 · AI · contact PI
Identifying HIV and related stigma in rural Haiti$133,272
K23 · FY2005 · AI